Solid Biosciences (SLDB) Research & Development (2017 - 2026)
Quarterly results put Research & Development at $46.1 million for Q1 2026, up 49.25% from a year ago — trailing twelve months through Mar 2026 was $155.6 million (up 43.4% YoY), and the annual figure for FY2025 was $140.3 million, up 45.52%.
Solid Biosciences has reported Research & Development over the past 10 years, most recently at $46.1 million for Q1 2026.
- Research & Development reached $46.1 million in Q1 2026 per SLDB's latest filing, up from $38.1 million in the prior quarter.
- Across five years, Research & Development topped out at $46.1 million in Q1 2026 and bottomed at $14.0 million in Q3 2022.
- Median Research & Development over the past 5 years was $23.2 million (2022), compared with a mean of $25.8 million.
- The largest annual shift saw Research & Development dropped 27.42% in 2023 before it surged 99.12% in 2024.
- Over 5 years, Research & Development stood at $21.3 million in 2022, then decreased by 27.42% to $15.5 million in 2023, then soared by 99.12% to $30.8 million in 2024, then rose by 23.94% to $38.1 million in 2025, then increased by 20.99% to $46.1 million in 2026.
- Business Quant data shows Research & Development for SLDB at $46.1 million in Q1 2026, $38.1 million in Q4 2025, and $38.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 626,092.00 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 4.32 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -101.30 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 1.46 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 961.60 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 1.54 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | -2.30 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 364.87 Mn |
| 10 | Solid Biosciences | 713.77 Mn | 333.09 Mn | - | 46.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.14 Mn |
| Dec 31, 2025 | 38.14 Mn |
| Sep 30, 2025 | 38.86 Mn |
| Jun 30, 2025 | 32.42 Mn |
| Mar 31, 2025 | 30.91 Mn |
| Dec 31, 2024 | 30.77 Mn |
| Sep 30, 2024 | 27.33 Mn |
| Jun 30, 2024 | 19.46 Mn |
| Mar 31, 2024 | 18.87 Mn |
| Dec 31, 2023 | 15.45 Mn |
| Sep 30, 2023 | 16.70 Mn |
| Jun 30, 2023 | 19.78 Mn |
| Mar 31, 2023 | 24.63 Mn |
| Dec 31, 2022 | 21.29 Mn |
| Sep 30, 2022 | 14.01 Mn |
| Jun 30, 2022 | 23.18 Mn |
| Mar 31, 2022 | 19.95 Mn |
| Dec 31, 2021 | 14.60 Mn |
| Sep 30, 2021 | 14.43 Mn |
| Jun 30, 2021 | 15.51 Mn |
| Mar 31, 2021 | 14.21 Mn |
| Dec 31, 2020 | 15.72 Mn |
| Sep 30, 2020 | 16.05 Mn |
| Jun 30, 2020 | 13.45 Mn |
| Mar 31, 2020 | 19.67 Mn |
| Dec 31, 2019 | 27.07 Mn |
| Sep 30, 2019 | 22.79 Mn |
| Jun 30, 2019 | 21.61 Mn |
| Mar 31, 2019 | 23.27 Mn |
| Dec 31, 2018 | 17.76 Mn |
| Sep 30, 2018 | 14.68 Mn |
| Jun 30, 2018 | 13.59 Mn |
| Mar 31, 2018 | 11.93 Mn |
| Dec 31, 2017 | 11.95 Mn |
| Sep 30, 2017 | 10.62 Mn |
| Jun 30, 2017 | 8.61 Mn |
| Mar 31, 2017 | 8.73 Mn |